ETS1 and ovarian cancer: Using the Transwell assay, we discovered that ETS1 downregulation greatly decreased ovarian cancer cell migration and invasion capacity, whereas ETS1 overexpression enhanced ovarian cancer cell migration and invasion (Fig. 2D).